Ergüven / Muramatsu / Bilir Midkine: From Embryogenesis to Pathogenesis and Therapy

1. Auflage 2012
ISBN: 978-94-007-4234-5
Verlag: Springer Netherland
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 338 Seiten

Reihe: Biomedical and Life Sciences (R0)

Carl Edward Sagan’s (1934-1996) one of the famous quotation was “Who are we? We find that we live on an insignificant planet of a humdrum star lost in a galaxy tucked away in some forgotten corner of a universe in which there are far more galaxies than people.“ From past to date, well-known molecules, enzymes, proteins, lipids and carbohydrates are studied in the pathogenesis of several diseases both as a diagnostic/prognostic biomarker and therapeutic agent. The underlying mechanism of unexplained diseases and failure of therapies are frequently studied with well-known biomarkers, but remain unclear in many cases. As Dr. Sagan said other keys are still waiting to be known in some forgotten corner of a body universe, we find strength to propose that one of them can be the growth factor with cytokine activity named “Midkine” This book summarizes the extensive up-to-date literature overeview with the lastest work of experts about midkine in a detailed format that conveys its role as botha pathologic factor and therapeutic agent.

Zielgruppe

Research

Autoren/Hrsg.

Ergüven, Mine

Muramatsu, Takashi

Bilir, Ayhan

Inhaltsverzeichnis

PART I:  General aspects of midkine.-1 General information on midkine.-2The role of midkine in neural development and patterning.-3Midkine-  A player in innate immunity.-4 Midkine/p63 axis in regulation of epithelial-mesenchymal transition.-5 Immunochemical methods for the detection of midkine in samples of human origin.-6 Circulating midkine in malignant, inflammatory, and infectious diseases: a systematic review.II Midkine and inflammation.-7 Midkine in inflammation and inflammatory diseases.-8 Rheumatoid arthritis and midkin.III Midkine and the cardiovascular system.-9 Midkine and heart failure.-10 Vascular restenosis and midkine.-11 The potential of MK through the renin-angiotensin system.IV Midkine and the nervous system.-12 Midkine and Multiple sclerosis.-13 MK gene transfer in brain infarction.-14 Midkine in psychiatric and neurodegenerative diseases.V Midkine  and the urogenital system, reproduction and aging.-15 Role of midkine in nephrogenesis and kidney Disease.-16 Midkine, a factor promoting cytoplasmic maturation of oocytes.-17 Endometriosis may be promoted by midkine: possible involvement of ovarian follicles.-18 Stem cells and midkine.-19 Midkine in skeletal physiology.VI Midkine and cancer.-20 Midkine  and chemotherapy resistance in cancers.-21 A  gene medicine with the midkine transcriptional regulation as new cancer therapeutics.-22 Midkine  as a tumor shared antigen.-23 Midkine in prostate cancer.-24 Midkine is a potential therapeutic target of hepatocellular carcinoma.-25 Midkine in glioblastoma with the modulator role switching autophagy to cell death or cell survival.-26 Colon cancer and midkine.-27 Osteosarcoma and midkine.Index.